Prokaryotic expression for fusion protein of human metapneumovirus and its preliminary application as an antigen for antibody detection.
- Author:
Ru-nan ZHU
1
;
Yuan QIAN
;
Lin-qing ZHAO
;
Yu SUN
;
Jie DENG
;
Fang WANG
Author Information
1. Capital Institute of Pediatrics, Peking University, Beijing 100020, China.
- Publication Type:Journal Article
- MeSH:
Adult;
Antibodies, Viral;
immunology;
Antigens, Viral;
genetics;
immunology;
Escherichia coli;
genetics;
Gene Expression;
Humans;
Immunoglobulin G;
blood;
immunology;
Infant;
Infant, Newborn;
Metapneumovirus;
genetics;
Middle Aged;
Plasmids;
genetics;
Protein Engineering;
Protein Subunits;
genetics;
immunology;
Viral Fusion Proteins;
genetics;
immunology
- From:
Chinese Journal of Virology
2011;27(2):144-150
- CountryChina
- Language:Chinese
-
Abstract:
To understand the effectiveness of prokaryotic expression of fusion protein (F) of human metapneumovirus (hMPV) and its application as antigen, F proteins from different genotypes of hMPV were expressed in prokaryotic expression system and purified by Ni-NTA affinity chromatography column. According to the hydrophobicity, antigen index and surface probability of F protein, the subunit 1 (F1) region of F protein was generated and expressed in E. Coil. BL21(DE3). The 6-His-F1 proteins with molecular weight of approximately 37 kD generated from hMPV of two genotypes were expressed efficiently mainly in inclusion body. The antigenicity and specificity of the expressed proteins were tested and confirmed by Western Blot using polyclonal antibody against hMPV and one serum specimen from a patient with confirmed hMPV acute infection,and polyclonal antibodies against human respiratory syncytial virus and parainfluenza virus 2 and 3. The results of preliminary use of the expressed proteins for detecting antibodies against hMPV in 457 serum specimens collected from different age groups in Beijing indicated that 66%-67% of sera in all age groups were positive. The positive rate of antibodies declined in children in age groups from birth to 2-year-old and then rose along with the increase in age, in which the lowest was in age group from 1 to 2-year-old and the highest in newborn and people older than 60 years. The data indicated the existence of maternal transferred antibodies against hMPV in infants and the risk of hMPV infections in children younger than 2 years old.
